ReviewFrontiers in psychiatry2026
Attention-deficit/hyperactivity disorder in India: epidemiology, diagnostic inequities, treatment gaps, and public mental health implications.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder and an emerging public health concern in India. This review summarizes current evidence on the epidemiology, diagnosis, treatment, environmental influences, and public health implications of ADHD in the Indian context. Reported prevalence estimates vary widely across regions and populations, reflecting differences in study design, diagnostic practices, awareness, and access to healthcare. Although DSM-5-based diagnostic frameworks and culturally adapted assessment tools are increasingly available, access to specialist evaluation and treatment remains uneven, particularly in rural and underserved areas. Current management strategies emphasize a multimodal approach combining pharmacotherapy, behavioral interventions, educational support, and family-centered care. However, treatment access and continuity are often limited by financial constraints, inadequate healthcare infrastructure, specialist shortages, and sociocultural barriers. The review also examines the potential influence of early-life adversity, environmental exposures, lifestyle factors, and pandemic-related disruptions on ADHD risk and symptom expression. Overall, the available literature highlights persistent challenges, including underdiagnosis, regional disparities in care, and important gaps in evidence. Strengthening epidemiological surveillance, improving equitable access to services, and supporting context-specific research are essential for improving ADHD outcomes in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.